“…[ 11 , 12 , 13 , 14 ] The vast majority of XB‐donors are based on monodentate iodine(I) derivatives with either a polyfluorinated or a N‐heterocyclic backbone, for example, the triazolium derivative 1 or the pyridinium derivative 2 (Figure 1 a), with cationic species being typically more reactive than neutral derivatives. [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ] Bidentate XB‐donors such as imidazolium 3 have been described as well and were found to have a significantly higher reactivity than monodentate analogues. [24] …”